Lv1
80 积分 2022-05-09 加入
Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review
6小时前
已完结
Efficacy and Safety of Dapagliflozin in Patients with CKD Stages 4-5
5个月前
已完结
A 10-Year Analysis of IgAN Management in China: Results from the CPO-IGAN
5个月前
已关闭
Baseline Characteristics and Associations of Using SGLT2 Inhibitors in IgA Nephropathy in China: Results from the CPO-IGAN
5个月前
已关闭
Efficacy and Safety of Dapagliflozin in Patients with CKD Stages 4-5
5个月前
已完结
Long-Term Outcomes in IgA Nephropathy
8个月前
已完结
Effects of Tai Chi or Conventional Exercise on Central Obesity in Middle-Aged and Older Adults
8个月前
已完结
A meta-analysis of randomized controlled clinical trials implications of acute treatment effects on glomerular filtration rate for long-term kidney protection
9个月前
已完结
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
9个月前
已完结
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
1年前
已完结
皖公网安备34019202002308
